Satsuma Pharmaceuticals Inc (STSA)
NASDAQ:STSA
Holding STSA?
Track your performance easily

Satsuma Pharmaceuticals (STSA) Financial Statements

0 Followers

Satsuma Pharmaceuticals Financial Overview

Satsuma Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Satsuma Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -10.74M$ -23.53M$ -15.14M$ -16.27M$ -15.51M
EBITDA$ -10.96M$ -23.51M$ -14.95M$ -16.12M$ -15.38M
Net Income Common Stockholders$ -10.27M$ -23.07M$ -15.14M$ -16.27M$ -15.52M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 41.37M$ 52.48M$ 64.44M$ 68.06M$ 78.51M
Total Assets$ 43.48M$ 54.94M$ 75.04M$ 80.15M$ 93.67M
Total Debt$ 116.00K$ 138.00K$ 172.00K$ 205.00K$ 823.00K
Net Debt$ -41.25M$ -52.34M$ -64.26M$ -67.86M$ -77.69M
Total Liabilities$ 5.83M$ 8.12M$ 6.66M$ 7.96M$ 6.69M
Stockholders Equity$ 37.63M$ 46.82M$ 68.38M$ 72.19M$ 86.98M
Cash Flow-
Free Cash Flow$ -11.38M$ -12.23M$ -13.42M$ -12.00M$ -14.34M
Operating Cash Flow$ -11.38M$ -12.09M$ -13.42M$ -11.69M$ -14.32M
Investing Cash Flow$ 14.48M$ -12.05M$ 20.51M$ 14.57M$ 20.34M
Financing Cash Flow-$ 17.00K$ 9.70M$ -478.00K$ -500.00K
Currency in USD

Satsuma Pharmaceuticals Earnings and Revenue History

Satsuma Pharmaceuticals Debt to Assets

Satsuma Pharmaceuticals Cash Flow

Satsuma Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis